Roger Freeman Net Worth & Insider Trades
Roger Freeman - Director, Mednax, Inc
What is Roger Freeman's Net Worth?
The current estimated net worth of Mednax, Inc's Director, Roger Freeman, is estimated to be about $1.75M . Roger Freeman owns about 2,400 units of Mednax, Inc common stock. In the last 5 years at Mednax, Inc, Roger Freeman has sold an estimated value of $2.57M worth.
What is Roger Freeman's Past Insider Trading?
Roger Freeman's largest purchase order was 14,126 units , worth over $601.03K on November 9, 2012. Roger Freeman's largest sale order was 14,926 units , worth over $1.13M on November 9, 2012. In total, Roger Freeman has made about 8 transactions over 5 years of their time at Mednax, Inc. Roger Freeman usually trades in June, with the busiest year in 2013 and 2012. The most recent transaction was a sale order of 275 units , worth over $25.48K on June 12, 2013.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ROGER FREEMAN
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Roger Freeman's Salary in 2020?
As Director of Mednax, Inc, Roger Freeman has a total base salary of $1 . Roger Freeman received compensation valued at about $7,597,254 in 2020 after becoming Director. The vast majority of their compensation came in the form of stock awards of $6,150,001 , other earnings, plans or compensations of $780,822 , and other compensation of $666,430 .
What is Roger Freeman's' Mailing Address?
- Mailing address is C/o Pediatrix Medical Group-Legal Dept., 1301 Concord Terrace Sunrise FL 33323 FL
Mednax, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Mark S. Ordan | 2020 | $471,014 | $1,999,992 | $3,000,006 | $709,016 | $258,654 | $6,438,682 |
| C. Marc Richards | 2020 | $157,197 | $700,008 | $944,087 | $157,104 | $8,612 | $1,967,008 |
| Roger Mack Hinson, M.D. | 2020 | $432,833 | $965,023 | $706,565 | $550,000 | $258,798 | $2,913,219 |
| Dominic J. Andreano | 2020 | $431,250 | $1,700,025 | $470,875 | $500,000 | $274,797 | $3,376,947 |
| Dominic J. Andreano | 2019 | $475,000 | $1,050,025 | - | $356,250 | $8,648 | $1,889,923 |
| Dominic J. Andreano | 2018 | $433,333 | $1,353,036 | - | $211,850 | $11,288 | $2,009,507 |
| John C. Pepia | 2020 | $371,875 | $500,001 | - | $318,750 | $108,780 | $1,299,406 |
| John C. Pepia | 2019 | $406,183 | $1,500,026 | - | $159,375 | $8,648 | $2,074,232 |
| Roger J. Medel, M.D. | 2020 | $1 | $6,150,001 | - | $780,822 | $666,430 | $7,597,254 |
| Roger J. Medel, M.D. | 2019 | $500,001 | $6,150,034 | - | $1,125,000 | $291,241 | $8,066,276 |
| Roger J. Medel, M.D. | 2018 | $1,000,000 | $8,000,040 | - | $669,000 | $268,977 | $9,938,017 |
| Stephen D. Farber | 2020 | $345,833 | $5,694,021 | - | $413,251 | $590,070 | $7,043,175 |
| Stephen D. Farber | 2019 | $550,000 | $2,400,008 | - | $412,500 | $36,649 | $3,399,157 |
| Stephen D. Farber | 2018 | $192,882 | $4,758,000 | - | $191,370 | $607,381 | $5,749,633 |
| Nicholas J. Nikolopoulos | 2020 | $431,250 | $1,300,008 | - | $500,000 | $349,169 | $2,580,427 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/893949/000119312521091206/d142151ddef14a.htm
What are Mednax, Inc's Past Insider Trades?
Mednax, Inc's most recent insider trade came on June 16, 2023 by James Swift who sold 13,193 units worth $186.55K . In the last 14 years, insiders at Mednax, Inc have sold an estimated value of $326.81M and bought an estimated value of $89.16M worth of shares. Insider trading is most common in June, with the busiest year in 2012. The most active traders at the company are MD Roger Medel, Director, Dominic J Andreano, EVP, and Pascal MD Goldschmidt, Director .
Pediatrix Medical Group, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||